Evidence map›Paper›PMID 35987614›Full record

ArticleBMC infectious diseases2022

Epidemiology of sexually transmitted infections: trends among patients screened for sexually transmitted infections in rwandan health facilities 2014-2020.

Jean Damascene Makuza, Phyumar Soe, Dahn Jeong, Marie Paul Nisingizwe, Donatha Dushimiyimana, Justine Umutesi, Ladislas Nshimiyimana, Clarisse Maliza, Janvier Serumondo, Eric Remera and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Jean Damascene MakuzaSchool of Population and Public Health, University of British Columbia, 2613 Melfa Lane, Vancouver, BC, Canada. jean.makuza@bccdc.ca.
Phyumar SoeSchool of Population and Public Health, University of British Columbia, 2613 Melfa Lane, Vancouver, BC, Canada.
Dahn JeongSchool of Population and Public Health, University of British Columbia, 2613 Melfa Lane, Vancouver, BC, Canada.
Marie Paul NisingizweSchool of Population and Public Health, University of British Columbia, 2613 Melfa Lane, Vancouver, BC, Canada.
Donatha DushimiyimanaRwanda Biomedical Centre, Kigali, Rwanda.
Justine UmutesiRwanda Biomedical Centre, Kigali, Rwanda.
Ladislas NshimiyimanaRwanda Biomedical Centre, Kigali, Rwanda.
Clarisse MalizaRwanda Biomedical Centre, Kigali, Rwanda.
Janvier SerumondoRwanda Biomedical Centre, Kigali, Rwanda.
Eric RemeraRwanda Biomedical Centre, Kigali, Rwanda.
Gallican Nshogoza RwibasiraRwanda Biomedical Centre, Kigali, Rwanda.
Albert TuyishimeRwanda Biomedical Centre, Kigali, Rwanda.
David J RiedelInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Rwanda Biomedical Center · RWUniversity of British Columbia · CABC Centre for Disease Control · CAMedizinische Hochschule Hannover · DEUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSexually Transmitted Infections (STIs) are of great global health concern. Currently, there are limited epidemiological data characterizing STIs in the general population in Rwanda. We assessed the national and regional epidemiology of STIs in Rwanda from 2014-2020 among patients syndromically screened for STIs in all health facilities in Rwanda.

methodsThis is a retrospective analysis of the trend of STIs epidemiology among screened patients at all health facilities in Rwanda using data from the Health Management Information System (HMIS) reporting. Adult patients (15 years and over) screened for STIs between July 2014 and June 2020 were included in the analysis. Outcomes of interest were the number of individuals screened for STIs and individuals diagnosed with at least one STI with a syndromic approach only or plus a test together.

resultsOverall, the number of individuals screened for STIs over the study period was 5.3 million (M) in 2014-2015, 6.6 M in 2015-2016, 6.3 M in 2016-2017, 6.7 M in 2017-2018, 6.2 M in 2018-2019, and 4.9 M in 2019-2020. There was a modest increase in the number of individuals diagnosed and treated for STIs from 139,357 in 2014-15 to 202,294 (45% increase) in 2019-2020. At the national level, the prevalence of STI syndromes amongst individuals screened at health facilities in Rwanda varied between 2.37% to 4.16% during the study period. Among the provinces, Kigali city had the highest prevalence for the whole 6 years ranging from 3.46% (95%CI: 3.41, 3.51) in 2014-2015 to 8.23% (95%CI: 8.15, 8.31) in 2019-2020.

conclusionFrom 2014 to 2020, the number of patients screened for STI syndromes in Rwanda varied between 4.9 M and 6.7 M. However, the prevalence of STIs among screened patients increased considerably over time, which could be associated with public awareness and improved data recording. The highest prevalence of all STIs was observed in urban areas and near borders, and private clinics reported more cases, suggesting the need to improve awareness in these settings and increase confidentiality and trust in public health clinics.

Indexed as

HIV InfectionsSexually Transmitted DiseasesAdultHealth FacilitiesHumansPrevalenceRetrospective StudiesRwandaSyndromeEpidemiologyRwandaSTIsSyndromesTrends

Identifiers

PMID35987614
PMCPMC9392439
OpenAlexW4292436092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.